Fundraising Fox
Epigenic Therapeutics
Founded 2021 · 17 employees on LinkedIn · 3 known investors
Find your way into Epigenic Therapeutics
Sign up to find every way you can get introduced to Epigenic Therapeutics
- Your email: who you already know at Epigenic Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Epigenic Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.
Founders & leadership
Investors · 3
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Epigenic Therapeutics do?
- Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.
- Who are Epigenic Therapeutics's investors?
- Epigenic Therapeutics's investors include OrbiMed, Qiming Venture Partners, Trinity Innovation Bioventure Singapore.